Lack of association between PCK1 polymorphisms and obesity, physical activity, and fitness in European youth heart study (EYHS)

Obesity

Volumn 18, Issue 10, 2010, Pages 1975-1980

  Vimaleswaran, Karani S ^a   Franks, Paul W ^a,b   Brage, Soren ^a   Grontved, Anders ^c   Wareham, Nicholas J ^a   Ekelund, Ulf ^a   Loos, Ruth J F ^a  

^a INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ADOLESCENT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DENMARK; ESTONIA; EXERCISE; FEMALE; FITNESS; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MORPHOMETRICS; MOTOR ACTIVITY; OBESITY;

ADOLESCENT; BODY WEIGHTS AND MEASURES; CHILD; CROSS-SECTIONAL STUDIES; DENMARK; ESTONIA; EXERCISE; FEMALE; GENOTYPE; HUMANS; MALE; MOTOR ACTIVITY; OBESITY; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHYSICAL FITNESS; POLYMORPHISM, GENETIC;

ANIMALIA; MUS;

EID: 77957161408     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.13     Document Type: Article

References (40)

1. Oberkofler H, Linnemayr V, Weitgasser R, et al. Complex haplotypes of the PGC-1alpha gene are associated with carbohydrate metabolism and type 2 diabetes. Diabetes 2004;53:1385-1393.
2. Romeo S, Sentinelli F, Cavallo MG, et al. Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: the -352 A>T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population. Int J Obes (Lond) 2008;32:413-420.
3. Gloria-Bottini F, Magrini A, Antonacci E, et al. Phosphoglucomutase genetic polymorphism and body mass. Am J Med Sci 2007;334:421-425.
4. Cao H, van der Veer E, Ban MR, et al. Promoter polymorphism in PCK1 (phosphoenolpyruvate carboxykinase gene) associated with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004;89:898-903.
5. Yu H, Thun R, Chandrasekharappa S, et al. Human PCK1 encoding phosphoenolpyruvate carboxykinase is located on chromosome 20q13.2. Genomics 1993;15:219-221.
6. Chang TJ, Lee WJ, Chang HM, Lee KC, Chuang LM. Expression of subcutaneous adipose tissue phosphoenolpyruvate carboxykinase correlates with body mass index in nondiabetic women. Metab Clin Exp 2008;57:367-372.
7. Rajas F, Jourdan-Pineau H, Stefanutti A, et al. Immunocytochemical localization of glucose 6-phosphatase and cytosolic phosphoenolpyruvate carboxykinase in gluconeogenic tissues reveals unsuspected metabolic zonation. Histochem Cell Biol 2007;127:555-565.
8. Lane RH, MacLennan NK, Hsu JL, Janke SM, Pham TD. Increased hepatic peroxisome proliferator-activated receptor-gamma coactivator-1 gene expression in a rat model of intrauterine growth retardation and subsequent insulin resistance. Endocrinology 2002;143:2486-2490.
9. Kang S, Bajnok L, Longo KA, et al. Effects of Wnt signaling on brown adipocyte differentiation and metabolism mediated by PGC-1alpha. Mol Cell Biol 2005;25:1272-1282.
10. Beale EG, Harvey BJ, Forest C. PCK1 and PCK2 as candidate diabetes and obesity genes. Cell Biochem Biophys 2007;48:89-95.
11. Franckhauser S, Muñoz S, Pujol A, et al. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes 2002;51:624-630.
12. Rosella G, Zajac JD, Baker L, et al. Impaired glucose tolerance and increased weight gain in transgenic rats overexpressing a non-insulin-responsive phosphoenolpyruvate carboxykinase gene. Mol Endocrinol 1995;9: 1396-1404.
13. Franckhauser S, Muñoz S, Elias I, Ferre T, Bosch F. Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to dietinduced insulin resistance and obesity. Diabetes 2006;55:273-280.
14. Hakimi P, Yang J, Casadesus G, et al. Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse. J Biol Chem 2007;282:32844-32855.
15. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 2001;86:5755-5761.
16. Lee JH, Reed DR, Li WD, et al. Genome scan for human obesity and linkage to markers in 20q13. Am J Hum Genet 1999;64:196-209.
17. Wegner L, Andersen G, Albrechtsen A, et al. Large-scale study of the -232C > G polymorphism of PCK1 in Type 2 diabetes. Diabet Med 2006;23:1140-1144.
18. Ludwig DS, Vidal-Puig A, OBrien RM, et al. Examination of the phosphoenolpyruvate carboxykinase gene promoter in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996;81:503-506.
19. Rees SD, Britten AC, Bellary S, et al. The promoter polymorphism -232C/G of the PCK1 gene is associated with type 2 diabetes in a UK-resident South Asian population. BMC Med Genet 2009;10:83.
20. Shin HD, Park BL, Kim LH, et al. Association of a polymorphism in the gene encoding phosphoenolpyruvate carboxykinase 1 with high-density lipoprotein and triglyceride levels. Diabetologia 2005;48:2025-2032.
21. Riddoch C, Edwards D, Page A, et al. The European Youth Heart Study- cardiovascular disease risk factors in children: rationale, aims, study design, and validation of methods. J Phys Act Health 2005;2:115-129.
22. Vimaleswaran KS, Franks PW, Brage S, et al. Absence of association between the INSIG2 gene polymorphism (rs7566605) and obesity in the European Youth Heart Study (EYHS). Obesity (Silver Spring) 2009;17: 1453-1457.
23. Brito EC, Vimaleswaran KS, Brage S, et al. PPARGC1A sequence variation and cardiovascular risk-factor levels: a study of the main genetic effects and gene x environment interactions in children from the European Youth Heart Study. Diabetologia 2009;52:609-613.
24. Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK, 1990. Arch Dis Child 1995;73:25-29.
25. Lohman TG, Roche AF, Martorell R (eds). Anthropometric Standardization Reference Manual. Human Kinetics Books: Champaign, IL, 1991.
26. Gutin B, Litaker M, Islam S, et al. Body-composition measurement in 9-11- y-old children by dual-energy X-ray absorptiometry, skinfold-thickness measurements, and bioimpedance analysis. Am J Clin Nutr 1996;63: 287-292.
27. Tanner JM. Growth at Adolescence, 2nd edn. Blackwell: Oxford, 1962.
28. Brage S, Wedderkopp N, Ekelund U, et al.; European Youth Heart Study (EYHS). Features of the metabolic syndrome are associated with objectively measured physical activity and fitness in Danish children: the European Youth Heart Study (EYHS). Diabetes Care 2004;27:2141-2148.
29. Ekelund U, Anderssen SA, Froberg K, et al.; European Youth Heart Study Group. Independent associations of physical activity and cardiorespiratory fitness with metabolic risk factors in children: the European youth heart study. Diabetologia 2007;50:1832-1840.
30. Sardinha LB, Andersen LB, Anderssen SA, et al. Objectively measured time spent sedentary is associated with insulin resistance independent of overall and central body fat in 9- to 10-year-old Portuguese children. Diabetes Care 2008;31:569-575.
31. Ekelund U, Sjöström M, Yngve A, et al. Physical activity assessed by activity monitor and doubly labeled water in children. Med Sci Sports Exerc 2001;33:275-281.
32. Hansen HS, Froberg K, Nielsen JR, Hyldebrandt N. A new approach to assessing maximal aerobic power in children: the Odense School Child Study. Eur J Appl Physiol Occup Physiol 1989;58:618-624.
33. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000;320:1240-1243.
34. Chang SP, Chen YH, Chang WC, Liu IM, Cheng JT. Merit of physical exercise to reverse the higher gene expression of hepatic phosphoenolpyruvate carboxykinase in obese Zucker rats. Life Sci 2006;79:240-246.
35. Kristensen PL, Møller NC, Korsholm L, et al. Tracking of objectively measured physical activity from childhood to adolescence: the European youth heart study. Scand J Med Sci Sports 2008;18:171-178.
36. Willer CJ, Speliotes EK, Loos RJ, et al.; Wellcome Trust Case Control Consortium; Genetic Investigation of ANthropometric Traits Consortium. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009;41:25-34.
37. Thorleifsson G, Walters GB, Gudbjartsson DF, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009;41:18-24.
38. Lindgren CM, Heid IM, Randall JC, et al.; Wellcome Trust Case Control Consortium; Procardis Consortia; Giant Consortium. Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet 2009;5:e1000508.
39. Heard-Costa NL, Zillikens MC, Monda KL, et al. NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet 2009;5:e1000539.
40. Meyre D, Delplanque J, Chèvre JC, et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet 2009;41:157-159.